674 related articles for article (PubMed ID: 9414296)
1. Cerebrovascular accidents in sickle cell disease: rates and risk factors.
Ohene-Frempong K; Weiner SJ; Sleeper LA; Miller ST; Embury S; Moohr JW; Wethers DL; Pegelow CH; Gill FM
Blood; 1998 Jan; 91(1):288-94. PubMed ID: 9414296
[TBL] [Abstract][Full Text] [Related]
2. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.
Castro O; Brambilla DJ; Thorington B; Reindorf CA; Scott RB; Gillette P; Vera JC; Levy PS
Blood; 1994 Jul; 84(2):643-9. PubMed ID: 7517723
[TBL] [Abstract][Full Text] [Related]
3. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Gill FM; Sleeper LA; Weiner SJ; Brown AK; Bellevue R; Grover R; Pegelow CH; Vichinsky E
Blood; 1995 Jul; 86(2):776-83. PubMed ID: 7606007
[TBL] [Abstract][Full Text] [Related]
4. Molecular characteristics of pediatric patients with sickle cell anemia and stroke.
Sarnaik SA; Ballas SK
Am J Hematol; 2001 Jul; 67(3):179-82. PubMed ID: 11391715
[TBL] [Abstract][Full Text] [Related]
5. Alpha thalassemia and stroke risk in sickle cell anemia.
Adams RJ; Kutlar A; McKie V; Carl E; Nichols FT; Liu JC; McKie K; Clary A
Am J Hematol; 1994 Apr; 45(4):279-82. PubMed ID: 8178798
[TBL] [Abstract][Full Text] [Related]
6. Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease.
de Montalembert M; Beauvais P; Bachir D; Galacteros F; Girot R
Eur J Pediatr; 1993 Mar; 152(3):201-4. PubMed ID: 8444244
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance and short- and long-term mortality rates. The SPRINT Study Group.
Behar S; Tanne D; Abinader E; Agmon J; Barzilai J; Friedman Y; Kaplinsky E; Kauli N; Kishon Y; Palant A
Am J Med; 1991 Jul; 91(1):45-50. PubMed ID: 1858828
[TBL] [Abstract][Full Text] [Related]
8. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
[TBL] [Abstract][Full Text] [Related]
9. Stroke in a cohort of patients with homozygous sickle cell disease.
Balkaran B; Char G; Morris JS; Thomas PW; Serjeant BE; Serjeant GR
J Pediatr; 1992 Mar; 120(3):360-6. PubMed ID: 1538280
[TBL] [Abstract][Full Text] [Related]
10. Stroke prevention and treatment in sickle cell disease.
Adams RJ
Arch Neurol; 2001 Apr; 58(4):565-8. PubMed ID: 11295986
[TBL] [Abstract][Full Text] [Related]
11. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.
Ashley-Koch A; Yang Q; Olney RS
Am J Epidemiol; 2000 May; 151(9):839-45. PubMed ID: 10791557
[TBL] [Abstract][Full Text] [Related]
12. Coinheritance of α-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia.
Belisário AR; Rodrigues CV; Martins ML; Silva CM; Viana MB
Hemoglobin; 2010; 34(6):516-29. PubMed ID: 21077759
[TBL] [Abstract][Full Text] [Related]
13. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids.
Strouse JJ; Hulbert ML; DeBaun MR; Jordan LC; Casella JF
Pediatrics; 2006 Nov; 118(5):1916-24. PubMed ID: 17079562
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
[TBL] [Abstract][Full Text] [Related]
15. [Screening of cerebral vasculopathy in sickle cell anemia children using transcranial Doppler].
Dorie A; Guindo A; Saro YS; Touré BA; Fané B; Dembelé AK; Diallo DA
Arch Pediatr; 2015 Mar; 22(3):260-6. PubMed ID: 25636211
[TBL] [Abstract][Full Text] [Related]
16. Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography.
Powars DR; Conti PS; Wong WY; Groncy P; Hyman C; Smith E; Ewing N; Keenan RN; Zee CS; Harold Y; Hiti AL; Teng EL; Chan LS
Blood; 1999 Jan; 93(1):71-9. PubMed ID: 9864148
[TBL] [Abstract][Full Text] [Related]
17. Intracranial Aneurysms in Sickle-Cell Disease Are Associated With the Hemoglobin SS Genotype But Not With Moyamoya Syndrome.
Birkeland P; Gardner K; Kesse-Adu R; Davies J; Lauritsen J; Rom Poulsen F; Tolias CM; Thein SL
Stroke; 2016 Jul; 47(7):1710-3. PubMed ID: 27301940
[TBL] [Abstract][Full Text] [Related]
18. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia.
Pegelow CH; Colangelo L; Steinberg M; Wright EC; Smith J; Phillips G; Vichinsky E
Am J Med; 1997 Feb; 102(2):171-7. PubMed ID: 9217567
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
Sumoza A; de Bisotti R; Sumoza D; Fairbanks V
Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the humeral head in sickle cell disease.
Milner PF; Kraus AP; Sebes JI; Sleeper LA; Dukes KA; Embury SH; Bellevue R; Koshy M; Moohr JW; Smith J
Clin Orthop Relat Res; 1993 Apr; (289):136-43. PubMed ID: 8472404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
